Healthy adults
Conditions
Interventions
Intake 1 capsule containing test food after dinner, for 8 weeks.
Intake 1 capsule containing no test food after dinner, for 8 weeks.
Sponsors
MARUDAI FOOD CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Men and women aged 30 years or older but under 60 years at the time of consent acquisition (2) Individuals scoring 50 points or higher on any of the following POMS2 paper-based subscales: Anger-Hostility (AH), Confusion-Bafflement (CB), Depression-Downcast (DD), Fatigue-Inertia (FI), or Tension-Anxiety (TA) (3) Individuals who have received prior explanation of the clinical trial and can provide written informed consent
Exclusion criteria
Exclusion criteria: (1) Individuals taking medications that may affect test results (e.g., antipsychotics, anxiolytics, antidepressants, antiparkinsonian drugs, antipsychotics, antiepileptics, anticoagulants, etc.) (2) Individuals regularly consuming specific health foods, foods with functional claims, or other so-called health supplements (e.g., foods claiming effects on cognitive function, stress relief, sleep improvement, etc.) that may affect test results (3) Individuals who have been hospitalized for treatment or undergone surgery due to cerebral infarction, cerebrovascular disease, cerebral contusion, or head injury (4) Individuals with a past or current history of serious conditions that could affect the trial, such as epileptic seizures, psychosis, or dementia (5) Individuals who habitually consume excessive amounts of tobacco or alcohol (6) Individuals with extremely irregular eating habits, or those with irregular daily rhythms such as shift workers or night workers (7) Individuals who have undergone neuropsychological testing within a hospital setting (8) Individuals with allergies to pharmaceuticals or foods (9) Pregnant individuals, breastfeeding individuals, or individuals planning to become pregnant during the trial period (10) Individuals currently participating in another clinical trial for a drug or health supplement, within 4 weeks of completing such a trial, or planning to participate in another clinical trial after giving consent for this trial (11) Individuals deemed unsuitable for participation in this trial by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Profile of Mood States 2nd Edition, Adult Version - Full Item Set Uchida-Kraepelin performance test | — |
Secondary
| Measure | Time frame |
|---|---|
| Urine test (vanillylmandelic acid, homovanillic acid) | — |
Countries
Japan
Contacts
Public ContactKenji Todoriki
Matsumoto Health Lab None
Outcome results
None listed